Jun 03, 2021 / 04:30AM GMT
Takaki Koga -
I am Takaki Koga, Polivy Lifecycle Leader at Chugai Pharmaceutical Company. Today, I will give you an overview of what Polivy is and then ask Dr. Izutsu to make his presentation.
The name of the product is Polivy Intravenous Infusion, 30 milligram or 140 milligrams, and the generic name is polatuzumab vedotin, genetical recombination. It's indications are relapsed or refractory diffuse large B-cell lymphoma, but the name of the disease is a bit long. And so I'd like to use the English abbreviation, DLBCL. The name Polivy has been coined with Po coming from its generic name, polatuzumab vedotin, liv standing for life and y derived from the symbol for an antibody as it is an antibody drug conjugate. Thus, its English name is Polivy and Japanese name, Polivy.
On development history, in overseas, development was started by Roche in 2011. In Japan, a Phase I study was started in 2014. And in the same year in overseas, a global Phase Ib/II study was started for second-line treatment of patients with relapsed or refractory follicular lymphoma, which includes those with DLBCL. This study
Chugai Pharmaceutical Co Ltd Information Meeting on Polivy Transcript
Feb 13, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers